Therapeutics And Clinical Risk Management

期刊中文名：治療學和臨床風險管理ISSN：1176-6336E-ISSN：1178-203X

該雜志國際簡稱：THER CLIN RISK MANAG，是由出版商Dove Medical Press出版的一本致力于發(fā)布醫(yī)學研究新成果的的專業(yè)學術(shù)期刊。該雜志以HEALTH CARE SCIENCES & SERVICES研究為重點，主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果，扼要報道階段性研究成果和重要研究工作的最新進展，選載對學科發(fā)展起指導作用的綜述與專論，促進學術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志，在國際上有很高的學術(shù)影響力。

基本信息：: 期刊簡稱：THER CLIN RISK MANAG; 是否OA：開放; 是否預警：否; Gold OA文章占比：99.36%

出版信息：: 出版地區(qū)：New Zealand; 出版周期：1 issue/year; 出版語言：English; 出版商：Dove Medical Press

評價信息：: 中科院分區(qū)：3區(qū); JCR分區(qū)：Q2; 影響因子：2.3; CiteScore：5.3

投稿咨詢加急咨詢

雜志介紹中科院JCR分區(qū) JCR分區(qū) CiteScore 投稿經(jīng)驗

雜志介紹

Therapeutics And Clinical Risk Management雜志介紹

《Therapeutics And Clinical Risk Management》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱治療學和臨床風險管理，本刊主要出版、報道醫(yī)學-HEALTH CARE SCIENCES & SERVICES領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2.3，最新CiteScore 指數(shù)為5.3。

本刊近期中國學者發(fā)表的論文主要有：

LncRNA AFAP1-AS1 Induces Gefitinib Resistance of Lung Adenocarcinoma Through the miR-653-5p/AGR2 Axis
Author: Zuo, Tao; Jiang, Ping; Fu, Jun; Zhang, Yongjian
Research on the Influence of the Allogeneic Bone Graft in Postoperative Recovery After MOWHTO: A Retrospective Study
Author: Zhong, Rui; Yu, Gang; Wang, Yingming; Fang, Chao; Lu, Shuai; Liu, Zhilin; Gao, Jingyu; Yan, Chengyuan; Zhao, Qichun
Identifying the Risk Factors for Postoperative Sore Throat After Endotracheal Intubation for Oral and Maxillofacial Surgery
Author: Zheng, Zhou-peng; Tang, Su-lin; Fu, Shao-lan; Wang, Qian; Jin, Li-wei; Zhang, Yan-li; Huang, Rong-rong
Thoracic Paravertebral Block Decreased Body Temperature in Thoracoscopic Lobectomy Patients: A Randomized Controlled Trial
Author: Yan, Yanhong; Geng, Jiao; Cui, Xu; Lei, Guiyu; Wu, Lili; Wang, Guyan

英文介紹

Therapeutics And Clinical Risk Management雜志英文介紹

Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.

中科院SCI分區(qū)

Therapeutics And Clinical Risk Management雜志中科院分區(qū)信息

2023年12月升級版

綜述：否

TOP期刊：否

大類：醫(yī)學 3區(qū)

小類：